Over the past decades, Ebolavirus outbreaks have significantly impacted people's health in African countries such as the Democratic Republic of the Congo (DRC). Ebola, Sudan, and Bundibugyo are the viruses responsible for most large African outbreaks.
As of March 2024, the DRC has had 15 documented Zaire Ebolavirus outbreaks, with one recording a case-fatality rate of 66%.
A recent analysis indicates one U.S. FDA-approved vaccine has successfully reduced the impact of Ebola outbreaks.
Ebola Vaccination Found Very Protective
Concomitant of IPV and nOPV2 Vaccines Suggested During Polio Outbreaks
The WHO Executive Board recently published a report following its 156th session, which provides an update on progress toward fully implementing and financing the Polio Eradication Strategy and the Polio Transition Framework.
Based on the September 2024 Strategic Advisory Group of Experts on Immunization (SAGE) meeting, the report was published on December 11, 2024.
Within this report, the Polio Oversight Board extended the Strategy by three additional years.